The Delhi High Court has recently restrained De Harbien Life Sciences Pvt. Ltd., a pharmaceutical company, from using the marks “NEFROKIND” and “SILOKIND.” The Court found these marks deceptively similar to Mankind Pharma Limited's well-known trademarks “MANKIND,” “KIND,” and other “KIND” formative marks.A Single Bench of Justice Manmeet Pritam Singh Arora passed the...
